These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2223340

  • 1. Dose-dependent effect of metoclopramide on cholinesterases and suxamethonium metabolism.
    Kao YJ, Tellez J, Turner DR.
    Br J Anaesth; 1990 Aug; 65(2):220-4. PubMed ID: 2223340
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood.
    Chemnitius JM, Haselmeyer KH, Gonska BD, Kreuzer H, Zech R.
    Pharmacol Res; 1996 Aug; 34(1-2):65-72. PubMed ID: 8981558
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuromuscular block by suxamethonium following treatment with histamine type 2 antagonists or metoclopramide.
    Turner DR, Kao YJ, Bivona C.
    Br J Anaesth; 1989 Sep; 63(3):348-50. PubMed ID: 2572248
    [Abstract] [Full Text] [Related]

  • 6. Influence of metoclopramide on plasma cholinesterase and duration of action of mivacurium.
    Skinner HJ, Girling KJ, Whitehurst A, Nathanson MH.
    Br J Anaesth; 1999 Apr; 82(4):542-5. PubMed ID: 10472219
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prolongation of succinylcholine block by metoclopramide.
    Kao YJ, Turner DR.
    Anesthesiology; 1989 Jun; 70(6):905-8. PubMed ID: 2658689
    [Abstract] [Full Text] [Related]

  • 9. Effect of metoclopramide and ranitidine on the inhibition of human AChE by VX in vitro.
    Bartling A, Thiermann H, Szinicz L, Worek F.
    J Appl Toxicol; 2005 Jun; 25(6):568-71. PubMed ID: 16167316
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro protection of plasma cholinesterases by metoclopramide from inhibition by mipafox.
    Petroianu G, Kühn F, Arafat K, Zuleger K, Missler A.
    J Appl Toxicol; 2004 Jun; 24(2):143-6. PubMed ID: 15052610
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hydrolysis of suxamethonium by different types of plasma.
    Hobbiger F, Peck AW.
    Br J Pharmacol; 1969 Sep; 37(1):258-71. PubMed ID: 4981001
    [Abstract] [Full Text] [Related]

  • 14. In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-dose exposure.
    Hasan MY, Nurulain SM, Arafat K, Naseer OP, Petroianu GA.
    J Appl Toxicol; 2004 Sep; 24(4):257-60. PubMed ID: 15300712
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the response to suxamethonium in post-partum and gynaecological patients.
    Ganga CC, Hayduk JV, Marx GF, Sklar GS.
    Anaesthesia; 1982 Sep; 37(9):903-6. PubMed ID: 7125165
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The inhibition of cholinesterases by pancuronium.
    Stovner J, Oftedal N, Holmboe J.
    Br J Anaesth; 1975 Sep; 47(9):949-54. PubMed ID: 1191483
    [Abstract] [Full Text] [Related]

  • 19. The relationship between the level of cholinesterase in plasma and the action of suxamethonium in animals.
    Hobbiger F, Peck AW.
    Br J Pharmacol; 1970 Dec; 40(4):775-89. PubMed ID: 4322043
    [Abstract] [Full Text] [Related]

  • 20. In vitro neuromuscular effects of valproic acid.
    Nguyen A, Ramzan I.
    Br J Anaesth; 1997 Feb; 78(2):197-200. PubMed ID: 9068341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.